Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
Provided By GlobeNewswire
Last update: Jan 13, 2025
Mr. Pasternak brings decades of global pharmaceutical leadership experience
Transition further highlights transformation of the Board to lead Context into next phase of growth
Read more at globenewswire.com0.9428
+0.11 (+13.05%)
Find more stocks in the Stock Screener
CNTX Latest News and Analysis
19 days ago - ChartmillUnusual volume stocks in Friday's sessionLet's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session.
20 days ago - ChartmillThese stocks that are showing activity before the opening bell on Thursday.The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
